EphrinB2 repression through ZEB2 mediates tumour invasion and anti-angiogenic resistance-Reference-Cited by-同舟云学术

EphrinB2 repression through ZEB2 mediates tumour invasion and anti-angiogenic resistance

Published:2016-07-29 Issue:1 Volume:7 Page:
ISSN:2041-1723
Container-title:Nature Communications
language:en
Short-container-title:Nat Commun

Author:

Depner C.,zum Buttel H.,Böğürcü N.,Cuesta A. M.,Aburto M. R.,Seidel S.,Finkelmeier F.,Foss F.,Hofmann J.,Kaulich K.,Barbus S.,Segarra M.,Reifenberger G.,Garvalov B. K.,Acker T.,Acker-Palmer A.

Publisher

Springer Science and Business Media LLC

Subject

General Physics and Astronomy,General Biochemistry, Genetics and Molecular Biology,General Chemistry

Link

http://www.nature.com/articles/ncomms12329.pdf

Reference70 articles.

1. Stupp, R. et al. Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N. Engl. J. Med. 352, 987–996 (2005).

2. Kerbel, R. S. Tumor angiogenesis. N. Engl. J. Med. 358, 2039–2049 (2008).

3. Norden, A. D., Drappatz, J. & Wen, P. Y. Antiangiogenic therapies for high-grade glioma. Nat. Rev. Neurol. 5, 610–620 (2009).

4. Bergers, G. & Hanahan, D. Modes of resistance to anti-angiogenic therapy. Nat. Rev. Cancer 8, 592–603 (2008).

5. Chinot, O. L. et al. Bevacizumab plus radiotherapy-temozolomide for newly diagnosed glioblastoma. N. Engl. J. Med. 370, 709–722 (2014).

Cited by 63 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The potential roles of HIF-1α in epithelial-mesenchymal transition and ferroptosis in tumor cells;Cellular Signalling;2024-10

2. Targeting the tumour vasculature: from vessel destruction to promotion;Nature Reviews Cancer;2024-08-29

3. N-cadherin dynamically regulates pediatric glioma cell migration in complex environments;Journal of Cell Biology;2024-03-13

4. Spatial transcriptomics of gastric cancer brain metastasis reveals atypical vasculature strategies with supportive immune profiles;Gastroenterology Report;2023-12-22

5. Eph receptors and ephrins in cancer progression;Nature Reviews Cancer;2023-11-23